LOGIN  |  REGISTER
Astria Therapeutics
Viking Therapeutics

Media Advisory: UnitedHealth Group Responds to Misinformation

December 13, 2024 | Last Trade: US$508.95 3.09 0.61

- / Dec 13, 2024 / Business Wire / UnitedHealth Group today issued the following update:

Claims approval rates

  • UnitedHealthcare approves and pays about 90% of medical claims upon submission. Importantly, of those that require further review, around one-half of one percent are due to medical or clinical reasons. Highly inaccurate and grossly misleading information has been circulated about our company’s treatment of insurance claims.

Whether the killer and his parents were UnitedHealthcare members

  • Regarding the murder of Brian Thompson, we are re-affirming that the killer and his parents were not UnitedHealthcare members.

We grieve the passing of our dear friend and colleague and continue to work closely with law enforcement and their investigation of this horrific crime.

About UnitedHealth Group

UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn.

Terns Pharmaceuticals

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB